Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is known that activation of neutrophils or monocytes leads to the formation of hydrogen peroxide and the release of
myeloperoxidase
(
MPO
). We found that sulfamethoxazole was chlorinated by the combination of
MPO
, hydrogen peroxide, and chloride. The product, N-chlorosulfamethoxazole, is reasonably stable but reacts rapidly with a variety of compounds. The same product was formed by the reaction between sulfamethoxazole and hypochlorous acid, and dapsone was also N-chlorinated by the
MPO
system or hypochlorous acid. Although N-chlorination was not observed when sulfamethoxazole or dapsone was incubated with activated neutrophils, this is presumably because the chloramine products react rapidly with the cells. When radiolabeled sulfamethoxazole was incubated with activated neutrophils, covalent binding was observed. When radiolabeled sulfamethoxazole was incubated with
MPO
and hydrogen peroxide in the presence of albumin, covalent binding to the albumin occurred. Although binding to albumin occurred in the absence of chloride, it was increased by the presence of chloride. This suggests that N-chlorosulfamethoxazole may be one of several reactive metabolites of sulfamethoxazole that covalently bind to neutrophils. We suspect that covalent binding of arylamine drugs, such as sulfamethoxazole, to activated leukocytes is responsible for some of the adverse reactions associated with these drugs, especially adverse reactions that involve leukocytes such as agranulocytosis or drug-induced
lupus
.
...
PMID:N-chlorination of sulfamethoxazole and dapsone by the myeloperoxidase system. 790 44
We describe 2 cases of a
lupus
syndrome induced by sulfasalazine in rheumatoid arthritis. All symptoms resolved and antihistone antibodies disappeared when sulfasalazine was discontinued. In one patient, perinuclear antineutrophil cytoplasmic antibodies with specificity for
myeloperoxidase
were found critically increased just before the occurrence of vasculitis.
...
PMID:Sulfasalazine induced lupus in rheumatoid arthritis. 791 4
Antineutrophil cytoplasmic autoantibodies (ANCA) have been used as markers of systemic vasculitides, including microscopic polyarteritis (MPA) and Wegener's granulomatosis. The diagnostic potential of ANCA assays together with antibodies against the neutrophil enzymes
myeloperoxidase
(
MPO
) and proteinase 3 for detecting a systemic vasculitis was tested in a Chinese patient population. 672 sera were received for ANCA assay, and ANCA detected by indirect immunofluorescence was positive in 73 sera from 42 patients. Of the 42 patients, 3 had cytoplasmic ANCA, while 39 had a perinuclear pattern. There was no patient with Wegener's granulomatosis. Two cytoplasmic ANCA positive patients suffered from ulcerative colitis. Another cytoplasmic ANCA positive patient was a carrier of human immunodeficiency virus. Of the 39 perinuclear ANCA positive patients, 10 had MPA. Eight of them were tested for anti-
MPO
antibody, and all were positive. Other immune disorders that were perinuclear ANCA positive included: 13 patients with
systemic lupus erythematosus
, 3 with mixed connective tissue disease, 1 with Goodpasture's syndrome, 2 with inflammatory bowel disease, and 2 patients with IgA nephropathy. Anti-
MPO
antibody was not specific for MPA, and 7 out of the 13 patients with
systemic lupus erythematosus
were anti-
MPO
antibody positive. Our study suggests that ANCA and anti-
MPO
antibody are not specific for MPA in a Chinese population. They would alert the clinician of the possibility of vasculitis, but a clinicopathological correlation is essential in making the diagnosis.
...
PMID:Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population. 791 85
A variety of autoantibodies have been associated with vasculitis, including that to neutrophils or to endothelial cells. Anti-neutrophil cytoplasmic antibodies (ANCA) have been described as sensitive and specific markers for active Wegener's granulomatosis (WG). ANCA in WG produces a characteristic cytoplasmic staining pattern (cANCA) and are directed against proteinase 3 (PR3-ANCA). PR3-ANCA occur in more than 90% of patients with extended WG, in 75% of patients with limited WG without renal involvement and in some 40% to 50% of patients with vasculitic overlap syndrome such as microscopic polyarteritis. Change in levels of cANCA precede disease activity and may be used as guidelines for treatment. Antibodies producing a perinuclear staining of ethanol-fixed neutrophils (pANCA) occur in a wide range of disease. They are directed against different cytoplasmic constituents of neutrophils. Among these, antibodies to
myeloperoxidase
(
MPO
-ANCA) are found in patients with idiopathic crescentic glomerulonephritis, the Churg-Strauss syndrome, polyarteritis nodosa and vasculitic overlap syndromes. Anti-endothelial cell antibodies (AECA) have been described in various autoimmune (
systemic lupus erythematosus
, scleroderma, rheumatoid arthritis) and vasculitic disorders (WG, polyarteritis nodosa, Kawasaki syndrome). They have been implicated in the pathogenesis of vascular injury common to these disorders.
...
PMID:[Autoantibodies associated with vasculitis]. 793 81
Serum soluble HLA (SHLA) class I antigens in patients with
systemic lupus erythematosus
(
SLE
) were examined by enzyme-linked immunosorbent assay. The primary antibody used was W6/32, anti-HLA class I mouse monoclonal antibody, and the secondary antibody was
peroxidase
-conjugated anti-mouse IgG antibody. The reactivity of SHLA class I antigens, the number of peripheral lymphocytes, and the clinical state of
SLE
were compared. The results were as follows; 1) Sixteen of 55 samples from
SLE
patients were SHLA class I antigen-positive (29%). 2) The reactivity of SHLA class I antigens was closely related to disease activity. 3) The number of lymphocytes and the reactivity of SHLA class I antigens were negatively correlated. 4) Nine of 23 samples from the active
SLE
patients were SHLA class I antigen-negative. Of these, 7 were from patients with a nephrotic syndrome due to lupus nephritis. It is concluded that SHLA class I antigens can be an useful marker for monitoring the clinical state of
SLE
.
...
PMID:Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus. 794 Jun 9
Drug-induced
lupus
is a serious side effect of certain medications, but the chemical features that confer this property and the underlying pathogenesis are puzzling. Prototypes of all six therapeutic classes of
lupus
-inducing drugs were highly cytotoxic only in the presence of activated neutrophils. Removal of extracellular hydrogen peroxide before, but not after, exposure of the drug to activated neutrophils prevented cytotoxicity. Neutrophil-dependent cytotoxicity required the enzymatic action of
myeloperoxidase
, resulting in the chemical transformation of the drug to a reactive product. The capacity of drugs to serve as
myeloperoxidase
substrates in vitro was associated with the ability to induce
lupus
in vivo.
...
PMID:Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. 772 10
The kidney is affected in a variety of vasculitic syndrome. Vasculitis represent an heterogeneous group of inflammatory disease concerning vessels. They can be considered as secondary in
systemic lupus erythematosus
, cryoglobulinemia, rheumatoid polyarthritis but also in infectious diseases (Streptococci, hepatitis B) in malignant disease and after drugs. However, in many circumstances, no causes are found. The discovery of autoantibodies directed against components of neutrophil cytoplasm (ANCA) represent a great progress in the understanding of vasculitis. ANCA are autoantibodies directed against neutrophil lysosomial enzymes, preferentially
myeloperoxidase
and proteinase 3. They are frequently found in patients with idiopathic necrotizing vasculitis, systemic or localized to the kidney (Wegener granulomatosis, microscopic periarteritis, pauci-immune necrotizing glomerulonephritis, Churg and Strauss syndrome and polyarteritis nodosa). Diagnostic and prognostic values are sure, although their presence is unconstant with variable percentage in relation with the type of vasculitis. The increase of ANCA level is not always related with disease relapse. Conversely, a permanent low level means a quiescent disease. At the present time, it is not known if ANCA play a pathogenetic role or if they constitute a marker of the disease.
...
PMID:[Kidney and vasculitis]. 805 72
Anti-neutrophil cytoplasmic antibodies (ANCA) are antibodies directed against enzymes that are found mainly within the azurophil or primary granules of neutrophils. There are 3 types of ANCA that can be distinguished by the patterns they produce by indirect immunofluorescence when tested on normal ethanol-fixed neutrophils. Diffuse fine granular cytoplasmic fluorescence (cANCA) is typically found in Wegener's granulomatosis, in some cases of microscopic polyarteritis and Churg Strauss syndrome, and in some cases of crescentic and segmental necrotising glomerulonephritis, but it is rare in other conditions. The target antigen is usually proteinase 3. Perinuclear fluorescence (pANCA) is found in many cases of microscopic polyarteritis and in other cases of crescentic and segmental necrotising glomerulonephritis. These antibodies are often directed against
myeloperoxidase
but other targets include elastase, cathepsin G, lactoferrin, lysozyme and beta-glucuronidase. The third group designated "atypical" ANCA includes neutrophil nuclear fluorescence and some unusual cytoplasmic patterns, and while a few of the target antigens are shared with pANCA, the others have not been identified. Sera that produce a pANCA or atypical ANCA pattern on alcohol-fixed neutrophils result in cytoplasmic fluorescence when formalin acetone fixation is used. pANCA or atypical ANCA occur in about 2/3 of all individuals with ulcerative colitis or primary sclerosing cholangitis, and they are found in a third of patients with Crohn's disease. The reported incidence of ANCA in rheumatoid arthritis and
SLE
varies considerably but the patterns are predominantly pANCA and atypical ANCA.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops. 809 May 92
Circulating antibodies to
myeloperoxidase
(
MPO
) have been described in a variety of vasculitic syndromes, drug-induced
SLE
and drug-induced nephritis. We have examined the autoantibody profile in acute sera from patients with antineutrophil cytoplasmic antibody-positive vasculitis (n = 8), drug-induced nephritis (n = 4), drug-induced
lupus
(n = 7),
SLE
(n = 27) and nephritis-associated with
SLE
(n = 17). Significant binding to purified
MPO
in ELISA was given by all sera from patients with vasculitis and drug-induced nephritis but ANA sought by indirect immunofluorescence on HEp-2 cells were not detected. Both anti-
MPO
and ANA were found in sera from patients with drug-induced
lupus
. Sera from patients with
SLE
or SLE nephritis did not contain high titres of anti-
MPO
antibodies but invariably contained ANA. Anti-
MPO
antibodies of both IgG and IgM classes were present in all sera from patients with drug-induced disease. Although the number of samples tested was small, sera from patients with drug-induced nephritis showed significantly greater median % binding of IgM to
MPO
compared with drug-induced
SLE
. Binding to
MPO
by IgG in these sera was not significantly different. These findings suggest that the mechanism of interaction between hydralazine and the immune system in the two drug-induced autoimmune diseases studied may contribute to their distinct clinical features.
...
PMID:Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. 816 72
Peripheral blood leukocytes contain a variety of enzymes that are capable of metabolising xenobiotics. The enzyme
myeloperoxidase
(
MPO
) appears to be the most important for drug metabolism.
MPO
is a
peroxidase
/oxidase and generates the powerful oxidant hypochlorous acid.
MPO
- or
MPO
-generated oxidants are capable of oxidizing a wide variety of compounds and a broad range of functional groups, especially those that contain nitrogen and sulfur. Leukocytes have a role in immune response; therefore, reactive intermediates generated by leukocyte metabolism of xenobiotics may have a role in idiosyncratic drug reactions, particularly those that are immune-mediated such as drug-induced
lupus
or agranulocytosis.
...
PMID:Myeloperoxidase-mediated activation of xenobiotics by human leukocytes. 823 77
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>